Fang W, Igaki H, Tachimori Y, Sato H, Daiko H, Kato H
Department of Surgery, National Cancer Center Hospital, Tokyo, Japan.
Ann Thorac Surg. 2001 Sep;72(3):867-71. doi: 10.1016/s0003-4975(01)02896-x.
The risk and benefit of esophagectomy with three-field lymph node dissection has not been well defined in elderly esophageal cancer patients.
A total of 441 patients underwent three-field lymph node dissection from 1986 to 1998. Patients were divided into two age groups: group 1 consisted of 79 patients aged 70 years or over, and group 2 consisted of 362 patients under 70 years of age. Patients' characteristics and surgical outcomes were compared between groups. Risk factors for morbidity, mortality, and survival of patients in group 1 were further studied by multivariate analysis.
Significantly more patients had multiorgan dysfunction preoperatively in group 1 (24; 30.4%) than in group 2 (34; 9.4%, p < 0.001). The overall (65.8% vs 61.6%, p = 0.483) and surgically related complication rates (41.8% vs 52.2%, p = 0.093) were similar, but significantly more organ failure (11.4% vs 5.0%, p = 0.031) and infection (22.8% vs 13.8%, p = 0.045), defined as medical complications, occurred in group 1. There was no significant difference in 30-day (3.8% vs 0.8%, p = 0.074) or in-hospital mortality (7.6% vs 3.3%, p = 0.082) between groups. The overall (40.9% vs 48.1%, p = 0.235) and cause-specific 5-year survivals (55.4% vs 59.1%, p = 0.688) were comparably good in both groups, but the risk of death due to causes other than esophageal cancer was much higher in the elderly (p = 0.028). Multiorgan dysfunction was an independent predictive factor in elderly patients for overall and medical morbidity, overall survival, and risk of death from causes other than esophageal cancer.
Esophagectomy with three-field lymph node dissection could be carried out safely in patients over 70 years of age with satisfactory long-term results. For elderly patients with multiorgan dysfunction, however, less invasive procedures might be more appropriate.
在老年食管癌患者中,三野淋巴结清扫术式的食管切除术的风险和益处尚未得到明确界定。
1986年至1998年间,共有441例患者接受了三野淋巴结清扫术。患者被分为两个年龄组:第1组由79例70岁及以上的患者组成,第2组由362例70岁以下的患者组成。比较两组患者的特征和手术结果。通过多因素分析进一步研究第1组患者发病、死亡和生存的危险因素。
第1组术前出现多器官功能障碍的患者(24例;30.4%)显著多于第2组(34例;9.4%,p<0.001)。总体并发症发生率(65.8%对61.6%,p=0.483)和手术相关并发症发生率(41.8%对52.2%,p=0.093)相似,但第1组发生的器官衰竭(11.4%对5.0%,p=0.031)和感染(22.8%对13.8%,p=0.045,定义为医疗并发症)显著更多。两组之间30天死亡率(3.8%对0.8%,p=0.074)或住院死亡率(7.6%对3.3%,p=0.082)无显著差异。两组的总体5年生存率(40.9%对48.1%,p=0.235)和病因特异性5年生存率(55.4%对59.1%,p=0.688)相当,但老年患者因食管癌以外原因导致的死亡风险要高得多(p=0.028)。多器官功能障碍是老年患者总体和医疗发病率、总体生存以及食管癌以外原因导致的死亡风险的独立预测因素。
对于70岁以上的患者,三野淋巴结清扫术式的食管切除术可以安全实施,长期效果良好。然而,对于有多器官功能障碍的老年患者,侵入性较小的手术可能更为合适。